Pharmafile Logo
Pharmafocus logo
Advanced Search
Vaccination

EMA backs GSK’s malaria vaccine for use in Africa

July 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Committee for Medicinal Products for Human USE, EMA, European Medicines Agency, GSK, WHO, malaria, world health organization

GSK has taken a significant step forward toward being the first company to bring a malaria vaccine to market, after …

News
EMA

EMA in push for more paediatric drug trials

July 24, 2015
Medical Communications, Research and Development EMA, European Medicines Agency, clinical trials, drug development, paediatrics

The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …

News
Keytruda image

European Commission approves Merck’s Keytruda for melanoma drug

July 23, 2015
Sales and Marketing

The European Commission has approved Merck’s Keytruda (pembrolizumab) as a skin cancer treatment. Keytruda, the company’s successful anti-PD-L1 therapy and …

News
MabThera

Cancer and immunology drugs drive strong Roche sales performance

July 23, 2015
Sales and Marketing Roche, Severin Schwan, financials

Sales at Roche rose 6% in the first half of 2015, buoyed by “significant growth of sales and immunology medicines”, …

News
alzheimers_brain

Lilly, Biogen and Roche debut Alzheimer’s disease drug results

July 22, 2015
Research and Development Alzheimer's, Alzheimer's disease, Biogen, Conference, Eli Lilly, Roche, lilly

Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …

News
Opdivo

BMS halts Opdivo kidney cancer trial early

July 22, 2015
Research and Development BMS, Bristol-Myers Squibb, European Commission, Kidney cancer, opdivo, renal cell carcinoma

Bristol-Myers Squibb has stopped its Phase III study of its immunotherapy drug Opdivo in people with kidney cancer early after …

News
NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015
Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …

News
rtorbett

New ABPI executive director appointed

July 21, 2015
Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Richard Corbett

The UK pharma trade body the ABPI has appointed Richard Corbett as its new executive director of commercial. Corbett will …

Appointment
Malthouse_Freeman

Parliamentary launch for UK life sciences group

July 21, 2015
Manufacturing and Production, Research and Development All Party Parliamentary Group on Life Sciences, Kit Malthouse, george freeman, government, lobbying, parliament

A Parliamentary body has been created to highlight the contribution the life sciences sector makes to the economy, and boost …

News

Amgen’s Repatha wins PCSK9 heart drug race

July 21, 2015
Sales and Marketing Amgen, European Commission, PCKS9, Repatha, evolocumab, high cholesterol

The European Commission has signed off on Amgen’s Repatha, making it the first in a new class of cholesterol-lowering drugs …

News
Novartis

Sandoz and pharma division boost Novartis sales

July 21, 2015
Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales

Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …

News

Novartis and Pfizer to close factories in India

July 21, 2015
Manufacturing and Production India, Novartis, Pfizer, Sandoz, manufacturing

Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …

News
FDA

FDA bans drug imports from Indian plant

July 21, 2015
Manufacturing and Production Emcure, FDA, GMP, Good Manufacturing Practices, India, compliance, manufacturing, production, safety

The FDA has blocked US imports from the manufacturing plants of a major Indian pharmaceutical firm over safety fears. The …

News
Egyptian flag

Valeant in $800 million deal for Amoun Pharma

July 20, 2015
Sales and Marketing Amoun, Egypt, MENA, Valeant, acquisitions

Valeant is striking out in the acquisitions market yet again, having agreed an $800 million deal to buy Egypt’s largest …

News
Janssen image

European Imbruvica approval for Janssen

July 20, 2015
Medical Communications, Sales and Marketing B-cell lymphoma, EC, European Commission, Janssen, Waldenström’s Macroglobulinemia, imbruvica, rare cancer

Janssen has received final European sign-off for its oncology treatment Imbruvica (ibrutinib) as a treatment option for adult patients with …

News
Sense About Science

Ruling in transparency case ‘due within days’

July 17, 2015
Research and Development EMIG, EU Clinical Trial Regulation, Ethical Medicines Industry Group, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …

News
Chugai

Chugai falls foul of ABPI code for close consultant relationship

July 17, 2015
Medical Communications, Sales and Marketing ABPI Code, Chugai, PMCPA, Prescription Medicines Code of Practice Authority

Bosses at Chugai have been rapped by the industry’s code of practice regulator, after a senior manager failed to declare …

News
WHO flag

Novartis receives WHO nod for malaria drug Coartem

July 17, 2015
Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization

The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …

News
AstraZeneca

AstraZeneca receives US approval for Iressa

July 16, 2015
Medical Communications, Sales and Marketing AstraZeneca, FDA, Iressa, lung cancer, non-small cell lung cancer

AstraZeneca’s lung cancer therapy Iressa has been approved by the FDA – four years after the company pulled it from the …

News

It’s time the industry spoke out about legal challenge to clinical trial transparency

July 16, 2015
Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …

Feature
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026